PAXIL TAB 20MG
GLAXOSMITHKLINE INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of PAXIL TAB 20MG in Canada?
Yes. PAXIL TAB 20MG has an active shortage reported to Health Canada (last updated June 23, 2026).
Why is PAXIL TAB 20MG not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will PAXIL TAB 20MG be available again?
The manufacturer's estimated resolution date is December 18, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PRO-PAROXETINE
PRO DOC LIMITEE
BIO-PAROXETINE
BIOMED PHARMA
MAR-PAROXETINE
MARCAN PHARMACEUTICALS INC
NRA-PAROXETINE
NORA PHARMA INC
AURO-PAROXETINE
AURO PHARMA INC
Other Products
APO-PAROXETINE
APOTEX INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-12-18
~35 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
01940481
Strength
20MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
PAROXETINE
Tier
Unrated
Last Updated
2026-06-23
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from GLAXOSMITHKLINE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02245127
DIN 02245126
DIN 02240835
DIN 02240836
DIN 02240837
1MG · DIN 02237820
2.5MG · DIN 02237821
DIN 02418401
120MCG · DIN 02540207
200MCG · DIN 02446588
100MCG · DIN 02446561
27.5MCG · DIN 02298589